ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Abstract Number: 2168

Training Objective Structured Clinical Examinations in a Clinical Immunology department: Expectations and Perceptions of Medical students at Graduating Level
Abstract Number: 2169

Bridging the Gap: A National Needs Assessment of Rheumatology Fellowship Training in Adolescent and Young Adult Care
Abstract Number: 2170

I Know It When I See It! Improving Visual Diagnosis Education in Rheumatology Fellowship Training
Abstract Number: 2171

Knowledge of Fertility and Infertility Treatments Among Physicians Treating Women with Rheumatic Diseases: FIT-KS Survey
Abstract Number: 2172

Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models
Abstract Number: 2173

Developing Musculoskeletal Ultrasound Clinical Electives: Bridging the Basic Sciences and Clinical Application in Undergraduate Medical Education
Abstract Number: 2174

Using Natural Language Processing to Identify Character Strengths in Rheumatology Fellowship Candidate Applications: A Feasibility Study
Abstract Number: 2175

Skin Manifestations of Rheumatic Diseases: Educating Providers to Improve Diagnostic Skills
Abstract Number: 2176

Addressing Hesitancy in JAK Inhibitor Use: Outcomes from Continuing Medical Education Reveal Confidence-Knowledge Gaps Among Community Rheumatologists
Abstract Number: 2177

A Rheumatologic Ultrasound (RhUS) Educational Framework: Expert Consensus on RhUS Skills for Adult Rheumatology Fellows in the United States
Abstract Number: 2178

Online Education Significantly Improved Rheumatologists’ Knowledge of the Diagnosis and Management of Sjögren’s Disease
Abstract Number: 2179

Educational online webinars of European Reference Network (ERN) on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ReCONNET) for patients, caregivers and healthcare professionals: six years’ experience
Abstract Number: 2180

Helping Hands: Curriculum using Simulators to Teach the Hand Exam and Assessment of Small Joint Swelling in Inflammatory Arthritis
Abstract Number: 2181

A Pilot High-Fidelity Simulation for Pediatric Rheumatology Learners
Abstract Number: 2182

Rheum for Improvement: A Needs Assessment Survey for an Internal Medicine Resident Curriculum

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].